Nemocnice Na Frantisku

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Atrial fibrillation2 trials
• Stroke1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Active, not recruiting2 trials

Lead sponsor

• Anthos Therapeutics, Inc.1 trial
• Janssen Research & Development, LLC1 trial

Running trials

• Active, not recruiting

  A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

  NCT05757869· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation

  NCT04755283· Phase 2· Anthos Therapeutics, Inc.· Source